JVM Co

JVM Co OCF Margin

The Operating Cash Flow Margin of JVM Co (054950.KQ) as of Nov 3, 2026 is 17.55 %. In the previous year, Operating Cash Flow Margin was 16.26 % — a change of 7.91% (higher).

OCF Margin

17.55 %

YoY

7.91%

Last updated:

Operating Cash Flow Margin of JVM Co is 2025 17.55 % . Operating Cash Flow Margin of JVM Co was 2024 16.26 % . It decreases by 7.91% higher compared to the previous year.

The JVM Co OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
19.21 KRW
Jan 1, 2019
16.86 KRW
Jan 1, 2020
17.15 KRW
Jan 1, 2021
22.52 KRW
Jan 1, 2022
10.40 KRW
Jan 1, 2023
19.05 KRW
Jan 1, 2024
16.26 KRW
Jan 1, 2025
17.55 KRW
The JVM Co OCF Margin history
YEAROCF MarginYoY
17.55 %+7.91%
16.26 %-14.65%
19.05 %+83.21%
10.40 %-53.83%
22.52 %+31.32%
17.15 %+1.73%
16.86 %-12.23%
19.21 %+13.31%
16.95 %+11.61%
15.19 %+1.23%
15.00 %-38.90%
24.56 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

Operating Cash Flow Margin of JVM Co is 17.55 % in 2025.

Operating Cash Flow Margin of JVM Co changed from 16.26 % to 17.55 %, representing a 7.91% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin JVM Co since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's JVM Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — JVM Co

All Key Metrics — JVM Co